Anti-ERBB2/ HER2/ CD340 monoclonal antibody
Anti-ERBB2/ HER2/ CD340 antibody for FACS & in-vivo assay
Go to HER2/ERBB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T14597-Ab-1/ GM-Tg-hg-T14597-Ab-2 | Anti-Human HER2/ERBB2 monoclonal antibody | Human |
GM-Tg-rg-T14597-Ab-1/ GM-Tg-rg-T14597-Ab-2 | Anti-Rat HER2/ERBB2 monoclonal antibody | Rat |
GM-Tg-mg-T14597-Ab-1/ GM-Tg-mg-T14597-Ab-2 | Anti-Mouse HER2/ERBB2 monoclonal antibody | Mouse |
GM-Tg-cynog-T14597-Ab-1/ GM-Tg-cynog-T14597-Ab-2 | Anti-Cynomolgus/ Rhesus macaque HER2/ERBB2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T14597-Ab-1/ GM-Tg-felg-T14597-Ab-2 | Anti-Feline HER2/ERBB2 monoclonal antibody | Feline |
GM-Tg-cang-T14597-Ab-1/ GM-Tg-cang-T14597-Ab-2 | Anti-Canine HER2/ERBB2 monoclonal antibody | Canine |
GM-Tg-bovg-T14597-Ab-1/ GM-Tg-bovg-T14597-Ab-2 | Anti-Bovine HER2/ERBB2 monoclonal antibody | Bovine |
GM-Tg-equg-T14597-Ab-1/ GM-Tg-equg-T14597-Ab-2 | Anti-Equine HER2/ERBB2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T14597-Ab-1/ GM-Tg-hg-T14597-Ab-2; GM-Tg-rg-T14597-Ab-1/ GM-Tg-rg-T14597-Ab-2; GM-Tg-mg-T14597-Ab-1/ GM-Tg-mg-T14597-Ab-2; GM-Tg-cynog-T14597-Ab-1/ GM-Tg-cynog-T14597-Ab-2; GM-Tg-felg-T14597-Ab-1/ GM-Tg-felg-T14597-Ab-2; GM-Tg-cang-T14597-Ab-1/ GM-Tg-cang-T14597-Ab-2; GM-Tg-bovg-T14597-Ab-1/ GM-Tg-bovg-T14597-Ab-2; GM-Tg-equg-T14597-Ab-1/ GM-Tg-equg-T14597-Ab-2 |
Products Name | Anti-HER2/ERBB2 monoclonal antibody |
Format | mab |
Target Name | HER2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Diagnostic target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-HER2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T14597 |
Target Name | HER2 |
Gene ID | 2064,13866,24337,697573,403883,751824,505709,100054739 |
Gene Symbol and Synonyms | c-ERB-2,c-ERB2,c-erbB-2,c-erbB2,c-neu,CD340,erb2,Erbb-2,ERBB2,HER-2,HER-2/neu,HER2,HER2/neu,l11Jus8,mKIAA3023,MLN 19,MLN-19,NEU,NGL,p185(erbB2),p185erbB2,TKR1,VSCN2 |
Uniprot Accession | P04626,P06494,O18735 |
Uniprot Entry Name | ERBB2_HUMAN,ERBB2_RAT,ERBB2_CANLF |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Diagnostics Biomarker, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Breast Cancer, Non-Small Cell Lung Cancer, gastric cancer, Lupus Glomerulonephritis |
Gene Ensembl | ENSG00000141736 |
Target Classification | Checkpoint-Immuno Oncology, Kinase |
The target: HER2, gene name: ERBB2, also named as CD340, HER-2, HER-2/neu, HER2, MLN 19, NEU, NGL, TKR1. This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.